| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.35B | 42.90B | 42.67B | 33.24B | 29.70B | 22.88B |
| Gross Profit | 27.34B | 24.92B | 25.41B | 19.10B | 17.66B | 13.51B |
| EBITDA | 18.78B | 16.51B | 18.42B | 11.80B | 10.96B | 8.55B |
| Net Income | 13.51B | 12.12B | 12.08B | 8.50B | 7.16B | 5.28B |
Balance Sheet | ||||||
| Total Assets | 64.39B | 53.16B | 49.14B | 39.25B | 32.90B | 25.86B |
| Cash, Cash Equivalents and Short-Term Investments | 19.14B | 12.25B | 24.23B | 15.29B | 14.99B | 9.12B |
| Total Debt | 4.55B | 3.75B | 3.21B | 2.52B | 2.59B | 2.47B |
| Total Liabilities | 33.02B | 20.87B | 20.57B | 15.17B | 12.15B | 10.37B |
| Stockholders Equity | 31.37B | 32.29B | 28.57B | 24.08B | 20.74B | 15.49B |
Cash Flow | ||||||
| Free Cash Flow | 9.07B | 4.62B | 12.44B | 7.69B | 8.91B | 6.15B |
| Operating Cash Flow | 15.89B | 11.02B | 17.30B | 12.04B | 11.40B | 8.43B |
| Investing Cash Flow | -7.94B | -4.50B | -14.28B | -9.43B | -5.32B | -4.66B |
| Financing Cash Flow | -7.91B | -8.06B | -7.02B | -5.37B | -1.89B | 1.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$3.61B | 7.35 | 9.86% | 3.74% | 11.89% | 27.80% | |
73 Outperform | HK$107.43B | 24.14 | 20.39% | ― | ― | ― | |
71 Outperform | HK$35.07B | 15.79 | 15.41% | 5.64% | 8.19% | 23.16% | |
64 Neutral | HK$534.88B | 30.61 | 42.43% | 1.73% | 4.14% | 7.35% | |
63 Neutral | HK$1.51B | 11.85 | 4.05% | ― | -0.48% | -29.65% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | HK$7.57B | 23.14 | 7.42% | 1.41% | 7.29% | -33.19% |